Protecting Patient Access to Clinical Trials in Europe
An all-encompassing revision of pharmaceutical laws from the European Commission aims to make medications more available, accessible and affordable. But these revisions could have unintended consequences for patients’ access to clinical trials and new treatments.
New Global Patient Alliance Is Raising Profile of Chronic Kidney Disease
A new global coalition, the Global Patient Alliance for Kidney Health, launched last week. With 17 member organizations spanning five continents, the Alliance hopes to improve screening access and early treatment for a serious but often neglected public health challenge: chronic kidney disease, or CKD.
Novo Projeto de Lei Mostra Promessa para Ensaios Clínicos no Brasil
Com a participação girando em torno de 2%, os ensaios clínicos no Brasil enfrentam desafios reais. Por isso, públicos interessados estão se unindo para entender o motivo disso – e encontrar soluções políticas.
New Policy Shows Promise for Clinical Trials in Brazil
With participation hovering at a meager 2%, clinical trials in Brazil face real challenges. Now stakeholders are coming together to understand why – and to find policy solutions.
How EU Legislation Could Threaten Clinical Trials
A new proposal from the European Commission stands to dramatically change the laws and regulations governing how new medicines are approved.
Clinical Trials Access Barriers Delay & Derail New Treatments
Making Clinical Trials Access a Global Priority
